Events
Home
FDA grants Breakthrough designation for BI 1482694 in lung cancer
FDA grants Breakthrough designation for BI 1482694 in lung cancer
FDA grants Breakthrough designation for BI 1482694 in lung cancer
1
2
3
4
5
